Petree Daniel H

Petree Daniel H is listed in filings as Director at Sutro Biopharma, Inc.. This profile follows SEC Form 4 activity through Dec 29, 2025, including 2 public disclosures. Recent filings connect the profile to Sutro Biopharma, Inc. (STRO). The current snapshot covers public activity from Jun 10, 2025 to Dec 29, 2025. Reported amounts are shown as $15.6K to $42.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.